Quarterly report pursuant to Section 13 or 15(d)

REVENUE

v3.24.1.1.u2
REVENUE
3 Months Ended
Mar. 31, 2024
Revenue from Contract with Customer [Abstract]  
REVENUE

4. REVENUE

The Company disaggregates revenue between continuing operations and discontinued operations.  Revenue streams from contracts with customers depicts the nature, amount, timing and uncertainty of its revenue and cash flows as affected by economic factors. Commercial insurance consists of neuromonitoring cases whereby a patient has healthcare insurance that we bill. Facility billing consists of neuromonitoring cases whereby the Company has an agreement to bill the medical facility for patients that do not have health care insurance.  

The Company does not have any contract assets or contract liabilities as of or during the three months ended March 31, 2024 or 2023 or as of December 31, 2023.

The Company’s revenue is as follows (in thousands):

Three Months Ended March 31, 

2024

    

2023

Managed service agreements and other

$

9

$

115

Accounts Receivable

A summary of the accounts receivable, net, by revenue stream is as follows (in thousands):

March 31, 

December 31,

    

2024

    

2023

Technical service

$

752

 

$

1,308

Professional service

1,191

2,293

Other

 

122

 

Total receivables, net

$

2,065

$

3,601

The concentration of accounts receivable, net, by payor as a percentage of total accounts receivable is as follows:

As of March 31,

As of December 31,

2024

    

2023

Commercial insurance

68

%

82

%

Facility billing

26

%

18

%

Other

6

%

%

Total

 

100

%

100

%